Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Cancer

Explore clinical trials studying Fallopian Tube Cancer. Study availability and eligibility vary by location and protocol.

335 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Cancer trial results

Completed

Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy

NCT00318370

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +21 more
Locations
  • Sharp HealthCare San Diego, California, United States
  • St. Vincent Gynecologic Oncology Indianapolis, Indiana, United States
  • Hematology and Oncology Specialists, LLC Covington, Louisiana, United States
  • Jayne Gurtler, M.D. Metairie, Louisiana, United States
View all 20 locations
View Trial Details
Completed

Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer

NCT00003636

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Hospital de Clinicas "Jose De San Martin" Buenos Aires, Argentina
  • Shaare Zedek Medical Center Buenos Aires, Argentina
  • Karl-Franzens-University Graz Graz, Austria
  • Innsbruck Universitaetsklinik Innsbruck, Austria
View all 65 locations
View Trial Details
Completed

A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment

NCT00421889

Conditions
Adnexal Diseases, Bladder Cancer, Carcinoma, +27 more
Locations
  • Gynecologic Oncology Associates Newport Beach, California, United States
  • Research Facility Orlando, Florida, United States
  • Hematology and Oncology Specialists, LLC Covington, Louisiana, United States
  • Hematology & Oncology Specialists, LLC Metairie, Louisiana, United States
View Trial Details
Completed

UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00072267

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada
  • Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada
  • Ottawa Regional Cancer Centre Ottawa, Ontario, Canada
  • Princess Margaret Hospital Toronto, Ontario, Canada
View Trial Details
Completed

A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT00096993

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Univ. of Alabama at Birmingham Birmingham, Alabama, United States
  • Comprehensive Cancer Institute Huntsville, Alabama, United States
  • Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States
  • Arizona Cancer Center Tucson, Arizona, United States
View all 41 locations
View Trial Details
Completed

Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer

NCT01196741

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Addenbrooke's Hospital Cambridge, Cambridgeshire, United Kingdom
  • St Bartholomew's Hospital London, Greater London, United Kingdom
  • University College London Hospital London, Greater London, United Kingdom
  • Guy's Hospital London, Greater London, United Kingdom
View Trial Details

Related conditions